newsfilter
← Latest News
GlobeNewswire·

Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen's 42nd Annual Health Care Conference

CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief e